Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abraxane, activist, adjunct, advocating, al, Allied, allocation, alopecia, altogether, Amsterdam, antibody, ascending, aspect, Auer, awaiting, bankruptcy, baricitinib, Barn, basal, baseline, belonging, Biocidal, Boglione, Brazil, broadened, brochure, Canada, cervical, cessation, chosen, Cleveland, CLL, Comandone, compassionate, complicated, CRDE, CSR, cybersecurity, DCGI, delivery, denial, Deposit, dissolution, dissolved, downturn, DRDO, DRL, drop, dropping, dynamic, ECOG, economy, endemic, endometrial, ependymoma, eradicate, ESG, Eurasia, exacerbate, extramedullary, fatality, FDCA, febrile, figure, freestanding, geopolitical, GLP, Gonzalez, GSK, hair, Hurdle, Hyderabad, HYDROCHLORIDE, IB, ID, IIT, IMM, imposition, impossible, India, infeasible, influenza, insert, instability, internationally, interstitial, IQVIA, irreversible, Israel, JAK, jeopardize, Karol, KK, Korea, Kumar, lender, lessened, leverage, leveraged, leveraging, Lilly, London, lymphocytic, Lynparza, MAD, Manchester, Marcinkiewicz, Med, Mexico, MHRA, military, misappropriation, moderate, molnupiravir, morbidity, MSCNRIO, NCE, neighboring, neutropenia, nirmatrelvir, NJ, notably, occasionally, Oncologist, OS, outweigh, pace, pazopanib, Petrelli, Pfizer, PFS, pharmacy, PK, placebo, Pozna, Prim, prolonged, pursuit, quantity, question, rationing, reaction, recall, RECIST, reconsider, redacted, Reddy, regenerative, Regeneron, registry, rescind, rescinded, resume, revocation, Riverside, RPDPRV, SAD, SAE, Sahu, Salvage, scenario, seizure, shortly, Singapore, situation, slight, SLL, SoC, social, solution, subpopulation, sunset, SUSAR, Suspected, switched, Tarceva, technical, technically, testicular, thirteen, thyroid, timeline, transient, unemployment, unexpired, unredacted, unscheduled, unstable, unwilling, URPL, usage, venetoclax, verify, virtual, visit, waived, wave, weaken, week, wider, withdrew, workforce, Zealand, zone
Removed:
absorption, accepting, addressing, aforementioned, Annex, attractive, automatically, awarded, back, category, characterizing, connected, converted, cope, coupled, custody, Cytarbine, declared, denominator, deployed, die, discovered, earliest, economically, Excellence, excretion, fact, fall, Federation, float, golden, graph, IMS, insured, intermediate, irrevocably, Jumpstart, killing, lag, liquid, move, multiplied, negotiated, numerator, obligate, optimistic, outline, outsourced, parachute, planning, play, prophylactic, prosecuting, provisional, recording, referring, remediation, repeat, represented, requesting, resale, reviewing, rotation, Roth, Russian, segregation, settled, shelf, sought, sound, SPORE, stating, stimulate, succumbed, surveillance, TLS, toxicokinetic, toxicology, Turkmenistan, twelve, vast, Wall, Western
Filing tables
Filing exhibits
MBRX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 24, 2022, with respect to the consolidated financial statements included in the Annual Report of Moleculin Biotech, Inc. on Form10-K for the year ended December 31, 2021. We consent to the incorporation by reference of said report in the Registration Statements of Moleculin Biotech, Inc. on Forms S-1 (File No. 333-224243, File No. 333-226146 and File No. 333-227845), on Forms S-3 (File No. 333-219434, File No. 333-252676, File No. 333-235686 and File No. 333-256627) and on Forms S-8 (File No. 333-212619, File No. 333-225867 and File No. 333-248240).
/s/ GRANT THORNTON LLP
Houston, Texas
March 24, 2022